Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Towers Regulatory News (HTWS)

Share Price Information for Helios Towers (HTWS)

Share Price is delayed by 15 minutes
Get Live Data
213.80    1.80 (0.85%)
Bid:
212.80
Ask:
213.20
Spread: 0.40 (0.188%)
Market Cap: £2.18b
HTWS Live PriceLast checked at - London Stock Exchange

Intraday Helios Towers Share Chart

Transaction in Own Shares

24 Feb 2026 07:00

RNS Number : 0766U
Helios Towers PLC
24 February 2026
 

Helios Towers plc

Share Buyback Programme - Transactions in Own Securities

Helios Towers plc (the "Company") announces that on 23 February 2026 it has purchased a total of 96,332 of its ordinary shares of £0.01 each ("Ordinary Shares"), through Merrill Lynch International ("MLI") as detailed below:

Date of purchase:

23/02/2026

Number of Ordinary Shares purchased:

96,332

Highest price paid per Ordinary Share (pence per Ordinary Share):

199.4000

Lowest price paid per Ordinary Share (pence per Ordinary Share):

196.8000

Volume weighted average price paid per Ordinary Share (pence per Ordinary Share):

198.3417

The Company intends to cancel the purchased Ordinary Shares and does not intend to hold any of the purchased Ordinary Shares in treasury.

The purchases form part of the Company's share buyback programme as announced on 6 November 2025.

Following settlement of the above purchases and cancellation of the purchased Ordinary Shares, the Company's total number of Ordinary Shares in issue shall be 1,040,418,228 Ordinary Shares. The figure of 1,040,418,228 Ordinary Shares may be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No.596/2014 (the Market Abuse Regulation), as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended, a detailed breakdown of individual trades made by Merrill Lynch International on behalf of the Company as part of the share buyback programme is set out below.

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

LEI number of Helios Towers plc: 213800DGC7GS4XCHCU30

Schedule of Purchases

 

Aggregate information:

Trading venue

 

Weighted average price(pence per Ordinary Share)

Aggregated volume

London Stock Exchange (LSE)

198.3558

53,300

Chi-X (CHIX)

198.2984

17,000

BATE (BATE)

198.4053

19,522

Turqoise (TRQX)

198.1492

6,510

Transaction Details:

 

Issuer name:

Helios Towers plc

ISIN:

GB00BJVQC708

Intermediary name:

Merrill Lynch International

Intermediary code:

MLILGB3LELE

Time zone:

UKT

Currency:

GBP

Individual Transactions:

 

Please see attached PDF for full list of transactions.

http://www.rns-pdf.londonstockexchange.com/rns/0766U_1-2026-2-23.pdf

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSAKNBKFBKDKBB
Date   Source Headline
20th Jun 20246:02 pmRNSHolding(s) in Company
20th Jun 20243:24 pmRNSDirector/PDMR Shareholding
19th Jun 20245:44 pmRNSHolding(s) in Company
19th Jun 20247:00 amRNSRESULTS OF SECONDARY PLACING OF HELIOS TOWERS PLC
18th Jun 20245:05 pmRNSPROPOSED SECONDARY PLACING IN HELIOS TOWERS PLC
31st May 20244:35 pmRNSTender Results Announcement
23rd May 20247:00 amRNSBond Refinancing
20th May 20248:15 amRNSConditional Redemption of Senior Notes
20th May 20248:14 amRNSLaunch of Senior Notes
20th May 20248:14 amRNSOffer to Purchase 2025 Notes
16th May 20247:00 amRNSQ1 2024 Results
10th May 20247:00 amRNSDirectorate Change
3rd May 20247:00 amRNSBlock Listing Six Monthly Return
2nd May 20243:41 pmRNSDirector/PDMR Shareholding
25th Apr 20243:40 pmRNS2024 Annual General Meeting Results
23rd Apr 20247:00 amRNSNotice of Q1 2024 Results Date & Conference Call
22nd Apr 20247:00 amRNSCredit rating upgrade
16th Apr 20242:29 pmRNSDirector/PDMR Shareholding
28th Mar 20248:57 amRNSTotal Voting Rights
25th Mar 202410:31 amRNSDoc re Annual Report and Financial Statements
20th Mar 202412:31 pmRNSDirector/PDMR Shareholding
19th Mar 20242:52 pmRNSHolding(s) in Company
19th Mar 20247:56 amRNSHolding(s) in Company
15th Mar 202412:52 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSResults for the year and quarter ended 31 Dec 2023
26th Jan 20249:00 amRNSDirectorate Change
18th Jan 20247:00 amRNSNotice of FY 2023 Results Date & Conference Call
3rd Nov 20237:05 amRNSBlock Listing Interim Review
2nd Nov 20237:00 amRNSQ3 2023 Results
16th Oct 20237:01 amRNSResults of capped tender offer
16th Oct 20237:00 amRNSResults of Tender Offer for Senior Notes
10th Oct 20237:00 amRNSNotice of Q3 2023 Results Date & Conference Call
3rd Oct 20231:29 pmRNSDirector/PDMR Shareholding
28th Sep 20231:34 pmRNSExtension of Early Tender Time
14th Sep 20237:05 amRNSNew Facilities and tender offer of Senior Notes
14th Sep 20237:00 amRNSUp to $400m Tender Offer for Senior Notes
3rd Aug 20237:00 amRNSHalf-year Report
4th Jul 20237:00 amRNSNotice of H1 2023 Results Date & Conference Call
23rd May 20231:39 pmRNSDirector/PDMR Shareholding
18th May 20232:00 pmRNSDirector/PDMR Shareholding
18th May 20232:00 pmRNSDirectorate Change
18th May 20237:00 amRNSQ1 2023 Results
3rd May 202311:25 amRNSBlock Listing Interim Review
27th Apr 20233:39 pmRNS2023 Annual General Meeting Results
17th Apr 20239:44 amRNSNotice of Q1 2023 Results Date & Conference Call
27th Mar 20232:16 pmRNS2022 Annual Report and 2023 Notice of AGM
16th Mar 20237:00 amRNSFinal Results
27th Jan 20237:00 amRNSNotice of FY2022 Results Date & Conference Call
15th Dec 20225:56 pmRNSHolding in Company
8th Dec 20222:55 pmRNSClosing of tower acquisition in Oman

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.